First Trust Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $39.9M | Sell |
|
|||||
|
2025
Q2 | $38.6M | Sell |
|
|||||
|
2025
Q1 | $41.7M | Sell |
|
|||||
|
2024
Q4 | $42.5M | Buy |
|
|||||
|
2024
Q3 | $47.4M | Buy |
|
|||||
|
2024
Q2 | $43.6M | Buy |
|
|||||
|
2024
Q1 | $8.95M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $61.7M | Sell |
|
|||||
|
2022
Q1 | $62.3M | Buy |
|
|||||
|
2021
Q4 | $62.2M | Sell |
|
|||||
|
2021
Q3 | $58.1M | Buy |
|
|||||
|
2021
Q2 | $58.9M | Sell |
|
|||||
|
2021
Q1 | $56.6M | Buy |
|
|||||
|
2020
Q4 | $54.7M | Buy |
|
|||||
|
2020
Q3 | $51.7M | Buy |
|
|||||
|
2020
Q2 | $46.3M | Buy |
|
|||||
|
2020
Q1 | $40.4M | Buy |
|
|||||
|
2019
Q4 | $48.6M | Buy |
|
|||||
|
2019
Q3 | $41.4M | Buy |
|
|||||
|
2019
Q2 | $33.3M | Buy |
|
|||||
|
2019
Q1 | $29.9M | Buy |
|
|||||
|
2018
Q4 | $23.8M | Buy |
|
|||||
|
2018
Q3 | $23.7M | Buy |
|
|||||
|
2018
Q2 | $21.6M | Sell |
|
|||||
|
2018
Q1 | $21.7M | Sell |
|
|||||
|
2017
Q4 | $22M | Buy |
|
|||||
|
2017
Q3 | $19.9M | Buy |
|
|||||
|
2017
Q2 | $19.5M | Buy |
|
|||||
|
2017
Q1 | $18.5M | Buy |
|
|||||
|
2016
Q4 | $15.6M | Buy |
|
|||||
|
2016
Q3 | $14.1M | Buy |
|
|||||
|
2016
Q2 | $12.1M | Buy |
|
|||||
|
2016
Q1 | $9.43M | Buy |
|
|||||
|
2015
Q4 | $7.41M | Buy |
|
|||||
|
2015
Q3 | $6.17M | Sell |
|
|||||
|
2015
Q2 | $7.1M | Buy |
|
|||||
|
2015
Q1 | $6.45M | Sell |
|
|||||
|
2014
Q4 | $6.18M | Buy |
|
|||||
|
2014
Q3 | $5.25M | Buy |
|
|||||
|
2014
Q2 | $4.92M | Sell |
|
|||||
|
2014
Q1 | $5.37M | Sell |
|
|||||
|
2013
Q4 | $5.41M | Buy |
|
|||||
|
2013
Q3 | $4.92M | Buy |
|
|||||
|
2013
Q2 | $4.58M | Buy |
|